Literature DB >> 8344104

Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland.

F Froehlich1, O Lamy, M Fried, J J Gonvers.   

Abstract

Studies on the complication rate of liver biopsy have hitherto been conducted in referral hospital centers. They are therefore not representative for general practice where liver biopsy is performed by specialists and nonspecialists. In a postal nationwide survey, we approached all gastroenterologists and hospital internists to assess the complication rate and practice (setting, needle type, use of ultrasonography) of percutaneous liver biopsy performed in 1989 in Switzerland for diffuse liver disease. Two hundred eighty questionnaires were mailed and 252 were returned (response rate 90.0%) 165 respondents (65.5%) performed 3501 biopsies while 87 respondents (34.5%) did not practice liver biopsy; 67.7% of biopsies were executed blindly and 32.3% were guided. Eight nonfatal and three fatal complications occurred. Hemorrhage was the most frequent complication (five cases) and was responsible for all three fatal outcomes. The overall complication rate was 0.31%, being distinctly lower in the group of gastroenterologists (0.11%) as compared to the group of internists (0.55%; P = 0.031). The complication rate was 1.68% in the group of internists performing fewer than 12 biopsies per year, while there was no complication in the group of internists performing more than 50 biopsies per year (P = 0.036). Complications were not related to the needle diameter or to the absence of ultrasonography before biopsy. In conclusion, this representative survey in Switzerland shows that the complication rate of liver biopsy is mainly related to the experience and training of the operator.

Entities:  

Mesh:

Year:  1993        PMID: 8344104     DOI: 10.1007/bf01308607

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  One-second needle biopsy of the liver.

Authors:  G MENGHINI
Journal:  Gastroenterology       Date:  1958-08       Impact factor: 22.682

2.  Liver biopsy. II. The risk of needle biopsy.

Authors:  N ZAMCHECK; O KLAUSENSTOCK
Journal:  N Engl J Med       Date:  1953-12-24       Impact factor: 91.245

3.  A 21-year experience with major hemorrhage after percutaneous liver biopsy.

Authors:  D B McGill; J Rakela; A R Zinsmeister; B J Ott
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

4.  [The problem of late complications of liver biopsy].

Authors:  E Wildhirt
Journal:  Munch Med Wochenschr       Date:  1970-06-26

Review 5.  Liver biopsy today. The Royal Free Hospital experience.

Authors:  S Sherlock; R Dick; D J Van Leeuwen
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

6.  [Ultrasound-assisted percutaneous blind puncture of the liver].

Authors:  G Judmaier; H Kathrein
Journal:  Ultraschall Med       Date:  1983-06       Impact factor: 6.548

7.  [Experience with nearly 20,000 blind liver punctures].

Authors:  E Wildhirt; E Möller
Journal:  Med Klin       Date:  1981-04-24

8.  Bleeding after liver biopsy.

Authors:  P Kondlapoodi
Journal:  West J Med       Date:  1982-07

9.  Percutaneous biopsy of the liver as a procedure for outpatients.

Authors:  C M Knauer
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

10.  Statement on outpatient percutaneous liver biopsy.

Authors:  W H Jacobs; S B Goldberg
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

View more
  40 in total

1.  Diagnostic approach to patients with cholestatic jaundice.

Authors:  N Assy; G Jacob; G Spira; Y Edoute
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

2.  Liver biopsy:complications and risk factors.

Authors:  Pornpen Thampanitchawong; Teerha Piratvisuth
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

3.  Sonographically guided puncture of the pancreas: incidence of complications, and risk factors.

Authors:  Michael Mueller; Richard Andrew Mason; Wolfgang Kratzer; Suemeyra Oeztuerk; Mark Martin Haenle
Journal:  J Med Ultrason (2001)       Date:  2012-07-04       Impact factor: 1.314

4.  Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha.

Authors:  Dariusz-Marek Lebensztejn; Maria-Elzbieta Sobaniec-Lotowska; Maciej Kaczmarski; Michael Voelker; Detlef Schuppan
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

5.  Delayed hemorrhage from hepatic artery after ultrasound-guided percutaneous liver biopsy: a case report.

Authors:  Fen-Yu Ren; Xi-Xu Piao; Ai-Lian Jin
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

6.  Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting.

Authors:  Hannah Collins; Grant Beban; John Windsor; Rishi Ram; David Orr; Nicholas Evennett; Benjamin Loveday
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

7.  Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease.

Authors:  Juan S Calle-Toro; Suraj D Serai; Erum A Hartung; David J Goldberg; Bradley D Bolster; Kassa Darge; Sudha A Anupindi
Journal:  Abdom Radiol (NY)       Date:  2019-03

8.  Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.

Authors:  Robert P Myers; Mercedes De Torres; Françoise Imbert-Bismut; Vlad Ratziu; Frédéric Charlotte; Thierry Poynard
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

9.  Routine ultrasound-guided liver biopsy versus echo-assisted procedure in viral chronic hepatitis.

Authors:  R Chiavaroli; P F Grima; P Calabrese; P Grima
Journal:  Radiol Med       Date:  2008-09-25       Impact factor: 3.469

10.  Influence of operator experience on performance of ultrasound-guided percutaneous liver biopsy.

Authors:  Patrick Chevallier; Frederic Ruitort; Alban Denys; Pascal Staccini; Marie Christine Saint-Paul; Denis Ouzan; Jean Paul Motamedi; Albert Tran; Pierre Schnyder; Jean Noël Bruneton
Journal:  Eur Radiol       Date:  2004-08-13       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.